7 May 2020 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: MR imaging is a useful and widely used evaluation for chordomas. Prior studies have classified chordomas into cell-dense type and matrix-rich type according to the ultrastructural features. However, the relationship between the MR imaging signal intensity and ultrastructural classification is unknown. We hypothesized that MR imaging signal intensity may predict both tumor ultrastructural classification and prognosis. MATERIALS AND METHODS: Seventy-nine patients with skull base chordomas who underwent 95 operations were included in this retrospective single-center series. Preoperative tumor-to-pons MR imaging signal intensity ratios were calculated and designated as ratio on T1 FLAIR sequence (RT1), ratio on T2 sequence (RT2), and ratio on enhanced T1 FLAIR sequence (REN), respectively. We assessed the relationships among signal intensity ratios, ultrastructural classification, and survival. RESULTS: Compared with the matrix-rich type group, the cell-dense type chordomas showed lower RT2 (cell-dense type: 1.90 ± 0.38; matrix-rich type: 2.61 ± 0.60 P < .001). The model of predicting cell-dense type based on RT2 had an area under the curve of 0.83 (95% CI, 0.75–0.92). In patients without radiation therapy, both progression-free survival (P = .003) and overall survival (P = .002) were longer in the matrix-rich type group than in the cell-dense type group. REN was a risk factor for progression-free survival (hazard ratio = 10.24; 95% CI, 1.73–60.79); RT2 was a protective factor for overall survival (hazard ratio = 0.33; 95% CI, 0.12–0.87); and REN was a risk factor for overall survival (hazard ratio = 4.76; 95% CI, 1.51–15.01). CONCLUSIONS: The difference in MR imaging signal intensity in chordomas can be explained by electron microscopic features. Both signal intensity ratios and electron microscopic features may be prognostic factors.
8 March 2025 in Epilepsia Open
Objective: To summarize the clinical features of collagen type IV alpha 1/2 chain (COL4A)1/2‐related epilepsy and the seizure outcomes of patients undergoing epilepsy surgery.Methods: We retrospectively analyzed the clinical, electroencephalography, and neuroimaging data; genetic characteristics; surgical details; and prognosis of 8 patients (4 boys) treated for COL4A1/2‐related epilepsy at Tsinghua University Yuquan Hospital.Results: Two of the probands had COL4A1 variants and six had COL4A2 variants. Four of the variants were de novo. Prenatal abnormalities consisted of intrauterine growth retardation and ventriculomegaly. Three patients had a low birth weight, and one had perinatal retinal hemorrhage. The median age of seizure onset was 8 months, with 75% (6/8) experiencing epilepsy before age 1. Status epilepticus occurred in 38% (3/8) of patients. All patients experienced focal seizures, and 50% (4/8) had focal epileptic spasms. Hemiparesis was observed in 88% (7/8) of patients, and all 8 had developmental delays. The median number of anti‐seizure drugs was 5, and all patients had drug‐resistant epilepsy. Seven patients had seizures localized to one of the posterior quadrants, consistent with the magnetic resonance imaging features of blurring of the gray‐white matter junction and positron emission tomography features of metabolic abnormalities. Other neuroimaging features included bilateral mild white matter abnormalities; unilateral porencephaly near the basal ganglia; ventriculomegaly; focal cerebral calcification; contralateral schizencephaly; and contralateral cortical thickening and cerebellar abnormalities. Six patients underwent unilateral posterior quadrant disconnection, five (83%) of whom had no recurrence for at least 11 months and experienced developmental improvement. No surgical complications were reported. Pathological examination revealed malformations of cortical development in all six surgical cases (five with focal cortical dysplasia [FCD] type Ia and one with FCD type II).Significance: The results of this case series suggest that early surgical intervention in patients with COL4A1/2‐related epilepsy with well‐defined epileptogenic zones may improve seizure control and developmental outcomes.Plain Language Summary: In this case series of eight patients, epilepsy related to variants in the collagen type IV alpha 1/2 chain genes was characterized by drug‐resistant localized seizures with an early onset, one‐sided muscle weakness, and developmental delay. Neuroimaging revealed various brain abnormalities. Structural abnormalities outside the seizure‐onset zone did not appear to affect surgical prognosis. Early surgical intervention in patients with well‐defined seizure‐onset zones improved seizure control and developmental outcomes.
21 April 2016 in Bone Abstracts
Objective: Multiple endocrine neoplasia type 1-related PHPT (MHPT) differs in many aspects from sporadic PHPT (SHPT). The aims of the study were to summarize the clinical features of Chinese MHPT and compare the severity of the disease with SHPT. Design and methods: A total of 40 MHPT cases (27 sporadic, seven families) and 169 SHPT patients of Chinese descent were retrospectively analyzed. X-rays and ultrasound were used to assess the bone and urinary system. Dual energy X-ray absorptiometry (DXA) were performed to measure bone mineral density (BMD). The present study was approved by the local Ethics Committee. Results: The mean age at diagnosis of PHPT in MHPT group was younger than SHPT group (45.0 vs 50.7 years, P=0.025). Compared with SHPT patients, MHPT patients showed lower prevalence of skeletal involvement (87.1% vs 57.5%, P<0.001) but higher prevalence of urolithiasis/renal calcification (40.2% vs 60.0%, P=0.024). MHPT patients showed higher phosphate level (0.84 vs 0.73 mmol/l, P<0.05) but lower ALP (103.0 vs 174.0 U/L, P<0.001) and PTH (4.0 vs 9.8×upper limit, P<0.001) levels than SHPT patients. There were no significant differences in BMD Z-scores at the lumbar spine and femoral neck between the two groups even after adjustment of age, sex, course of PHPT (P=0.829, 0.510 respectively). Compared with SHPT, the incidences of parathyroid hyperplasia and multi-glandular involvement were both higher in MHPT patients (both P<0.001). MEN1 gene mutations were detected in 27 MHPT cases. Nine mutations were novel, and one of which was deletion of exon 5 and 6. Conclusions: MHPT patients showed more common kidney complications but less common skeletal involvement despite a milder biochemical presentation compared with SHPT patients. MEN1 mutation detection rate was 79.4% and nine mutations were novel.
16 September 2025 in Epilepsia